BioVie Inc (BIVI)
0.4768
+0.01
(+1.21%)
USD |
NASDAQ |
May 21, 12:10
BioVie Cash from Investing (Quarterly): 0.00 for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 14.52M |
| June 30, 2023 | -1.796M |
| March 31, 2023 | -12.50M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 |
| Date | Value |
|---|---|
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.0099M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-12.50M
Minimum
Mar 2023
14.52M
Maximum
Sep 2023
0.0249M
Average
--
Median
Mar 2022
Cash from Investing (Quarterly) Benchmarks
| Adial Pharmaceuticals Inc | -- |
| Precision BioSciences Inc | -0.026M |
| Cardiff Oncology Inc | 4.636M |
| Jaguar Health Inc | -- |
| Entero Therapeutics Inc | 0.0882M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.852M |
| Cash from Financing (Quarterly) | 15.98M |
| Free Cash Flow | -35.23M |
| Free Cash Flow Per Share (Quarterly) | -0.1306 |
| Free Cash Flow Yield | -189.4% |